Find uplifting stories about heroes, innovations, and solutions
16391 results for "ovarian cancer research"
Mayo Clinic researchers discovered that brigatinib, a lung cancer drug, may help ovarian cancer patients overcome treatment resistance when combined with existing therapies. The breakthrough could transform care for women facing one of the deadliest cancers.
UC San Diego researchers discovered how to "re-educate" immune cells to attack aggressive ovarian cancer by blocking a protein and triggering omega-3 signals. The breakthrough could make existing treatments far more effective for patients with limited options.
A leukemia survivor and a researcher who beat cancer are driving groundbreaking pediatric cancer research at Purdue University, inspired by beloved student Tyler Trent. Their work focuses on making treatments safer and more effective for kids fighting cancer.
Japanese researchers discovered that ovarian cancer cells team up with other cells in the body to spread faster and resist treatment. The breakthrough could lead to new drugs that save thousands of lives each year.
Researchers discovered that ovarian cancer cells activate survival mode within hours of treatment, but an existing lung cancer drug can block this response. The breakthrough could help thousands of women whose tumors stop responding to therapy.
When Caitlin Koehler was diagnosed with an extremely rare ovarian cancer at 27, she trusted MD Anderson's expert team to create a personalized treatment plan. Now cancer-free after beating two recurrences, she's proof that specialized care makes all the difference for young adults facing rare diagnoses.
Hundreds of runners gathered at Philadelphia's Navy Yard for the 25th annual Sandy Sprint 5K, raising funds and hope for ovarian cancer research. Survivors and families honored loved ones while spreading crucial awareness about the disease often called "the silent killer."
Cancer survivors rang bells and shared stories as Marco Island's Imagination Ball combined timeless elegance with lifesaving purpose. The American Cancer Society fundraiser brought the community together to support research that could one day end cancer diagnoses.
The American Cancer Society's Game Changer Gala takes place this Saturday in Las Vegas, bringing together survivors and supporters to fund critical cancer research. Colon cancer survivor Tori Lyons will share her story at the event.
The NHS just approved a groundbreaking ovarian cancer treatment that works like a guided missile, targeting only cancer cells while leaving healthy tissue untouched. For women with platinum-resistant ovarian cancer who had almost no options left, this precision medicine marks a genuine turning point. #
Cambridge researchers discovered why lung and ovarian cancers return after chemotherapy and found a promising way to stop it. The breakthrough could help millions of patients facing cancer recurrence.
A dragon boat team of breast cancer survivors just launched their biggest fundraiser yet, pledging $150,000 for local cancer research while bringing patients, doctors, and researchers together. They're proving that the fight against cancer doesn't end with survival.
Cancer survivors and grieving parents are urging Iowa lawmakers to fund pediatric cancer research for the first time. The $3 million bill would help develop treatments designed for children, not just smaller doses of adult therapies.
Researchers created an AI tool that predicts which ovarian cancer treatments will work best for each patient right at diagnosis, using slides doctors already have. The breakthrough could help patients avoid ineffective chemotherapy and find better options faster.
Women with hard-to-treat ovarian cancer now have a breakthrough treatment that adds precious months to their lives while making them feel better. The targeted drug has been called the most significant advance in ovarian cancer care in over 20 years.
A Pennsylvania mom whose son beat kidney cancer six years ago is hosting her sixth annual fundraiser, which has already raised nearly $50,000 for pediatric cancer research. The event brings together cookies, superheroes, and a community determined to fund better treatments for kids.
After 25 years at NBC News, Kristen Dahlgren left her dream job to solve a problem she discovered during her own breast cancer treatment: life-saving vaccine research wasn't reaching patients fast enough. Now she's partnering with one of America's top cancer research institutes to change that.
Hundreds of women with hard-to-treat ovarian cancer will now receive a groundbreaking new therapy that extends life while dramatically reducing the debilitating side effects of traditional chemotherapy. The approval marks the first new ovarian cancer treatment on the NHS in two decades.
Five years cancer-free, 21-year-old Isabelle Ireland is speaking out about the critical need for pediatric cancer research funding. Her advocacy comes as Iowa lawmakers commit $3 million to help children fighting rare cancers like the one she beat.
A Dalhousie University lab just received $725,000 to develop a breakthrough immunotherapy for ovarian cancer, with help from a 73-year-old survivor who's turning her diagnosis into hope for future generations. The team is now preparing for clinical trials that could make treatment more affordable and accessible.
Showing 20 of 16391